Form 8-K - Current report:
SEC Accession No. 0000950170-25-045729
Filing Date
2025-03-27
Accepted
2025-03-27 07:30:09
Documents
13
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ck0001534133-20250327.htm   iXBRL 8-K 47619
2 EX-99.1 ck0001534133-ex99_1.htm EX-99.1 184078
3 GRAPHIC img205673473_0.jpg GRAPHIC 53662
  Complete submission text file 0000950170-25-045729.txt   437947

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001534133-20250327.xsd EX-101.SCH 26025
16 EXTRACTED XBRL INSTANCE DOCUMENT ck0001534133-20250327_htm.xml XML 4949
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 25775303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)